Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update to the study record.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays revision v3.6.2, replacing v3.6.0, indicating a small maintenance update to the page's version tag without altering study content.SummaryDifference0.1%

- Check32 days agoChange DetectedRecruitment status now shows the study is not currently enrolling participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the page revision note confirms the latest version.SummaryDifference0.4%

- Check39 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, indicating a newer version of the page. No study data or descriptions are altered.SummaryDifference0.0%

- Check61 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a new build/version of the ClinicalTrials.gov page. The provided changes show only the revision tag with no visible substantive content changes in the data provided.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now includes PubMed-linked study publication text in the Publications section, along with an informational note that it is auto-filled. The site revision indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.3%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.